Epidemiology, Infectious Diseases, Parasites

Gum Disease and Heart Health: What’s the hidden link? | Fusobacterium Nucleatum

Author Chandana Balasubramanian , 25-Sep-2024

Our oral health may be more connected to heart health than we once thought.

 

The bacterium Fusobacterium nucleatum (F.nucleatum) is known for causing gum disease and bad breath. Now, it’s also being linked to heart disease and impacts our cardiovascular health.

 

Overview

Studies show that infection with this bacterium can increase systemic inflammation when it spreads from the gums and enters the bloodstream, triggering inflammation and potentially damaging blood vessels.

 

It might even directly colonize the walls of arteries, contributing to plaque buildup. Plaque buildup in arteries restricts blood flow to the heart, increasing the risk of heart attacks and other cardiovascular diseases.

 

Globally, heart disease is the leading cause of death, according to the World Health Organization (WHO). While genetics heavily influences cardiovascular risk, other lifestyle factors like oral health may also play a key role.

 

Early detection and treatment of F. nucleatum infections could reduce cardiovascular events. Here’s how this bacteria may affect your heart and what you can take to lower your risk.

 

What is Fusobacterium nucleatum?

Fusobacteria are bacteria often found in the mouth, gut, and female reproductive tract. The most common species of this bacteria in humans are Fusobacterium nucleatum and Fusobacterium necrophorum.

Fusobacterium nucleatum can lead to chronic inflammation, which is linked to systemic health issues such as cardiovascular disease.

How is F. nucleatum related to periodontal disease (gum disease)?

F. nucleatum is one of the most common bacteria found in the mouth. Initially, this bacteria was considered harmless but was later linked to gum disease or periodontal infection. Studies found that its presence drastically—up to 10,000 times—in infected areas.

The presence of F. nucleatum is linked to various gum diseases (periodontitis), from mild gingivitis to more severe forms like chronic periodontitis. This bacterium can also cause endodontic infections (affecting the inside of a tooth and surrounding gum tissue), such as pulp necrosis.

F. nucleatum is often found in higher levels in people with gum disease, and its presence is linked to the severity of the condition. Environmental factors, like smoking and uncontrolled diabetes, can also boost the level of bacterial infection.

Animal studies show that F. nucleatum can lead to significant periodontal infections, causing bone loss and abscesses, especially when it works together with other harmful oral bacteria.

Recent findings also suggest that F. nucleatum may act as a bridge between gum disease and atherosclerosis.

How is gum disease connected to heart health?

In 1983, doctors recorded the first case of F. nucleatum causing pericarditis, an inflammation of the heart’s lining. However, it’s only in recent years that science has begun to understand how this oral bacterium may contribute to atherosclerosis, a serious condition where plaque builds up in the arteries.

Studies have shown that patients with periodontal disease are at a higher risk of developing coronary artery disease, with differences noted between sexes and statistical analyses highlighting the associated risks.

F.nucleatum impacts the heart by:

  • Triggering the body’s immune system, leading to inflammation
  • Elevating ‘bad’ cholesterol levels
  • Increasing levels of microRNAs that cause inflammation and higher cholesterol levels

 

1. Inflammation in F. nucleatum-mediated heart disease

F. nucleatum can trigger strong inflammatory responses in the body when the bacterium enters the bloodstream. It prompts immune cells called macrophages to become activated and adopt a pro-inflammatory state known as M1 polarization.

This change causes more foam cells—fat-filled cells that build up in artery plaques—which weaken the plaques and increases the risk of dangerous blockages.

Additionally, mice infected with F. nucleatum showed higher levels of proinflammatory cytokines. These cytokines in the plaque area may also help trigger the development of atherosclerosis.

2. Fat metabolism in F. nucleatum-mediated heart disease

F. nucleatum also affects how the body processes fats and cholesterol. It has been shown to reduce levels of high-density lipoprotein (HDL), which is considered “good” cholesterol, while increasing levels of oxidized low-density lipoprotein (ox-LDL), a harmful form of cholesterol associated with heart disease.

This imbalance may accelerate atherosclerosis development and promote plaque buildup in arteries.

3. mRNA regulation by microRNAs in heart disease

MicroRNAs (miRNAs) are tiny RNA molecules that don’t code for proteins but help control how genes work. They’re about 20-25 nucleotides long and bind to messenger RNA (mRNA). This either blocks the mRNA from making proteins or breaks it down. miRNAs can also help start protein production or influence how genes are read.

Recent studies identified miRNAs influenced by F. nucleatum play a role in regulating inflammation and cholesterol metabolism. Increased levels of microRNAs like miR-146a and miR-155 have been linked to higher plaque areas in arteries and may help explain how F. nucleatum contributes to heart disease.

What infections does F. nucleatum cause outside the oral cavity?

F. nucleatum can be seen outside the oral cavity and can affect a wide range of organs, including bones, lungs, joints, blood, abdomen, and pelvis.

 

F. nucleatum is now classified as an opportunistic pathogen. An opportunistic pathogen may not cause an infection in healthy individuals but does so when faced with a weakened immune system.

Diseases Linked to F.nucleatum include:

  • Gastrointestinal disorders
  • Colorectal cancer (the bacteria interacts with colorectal cancer cells)
  • Inflammatory bowel disease
  • Appendicitis
  • Adverse pregnancy outcomes
  • Chorioamnionitis
  • Preterm birth
  • Stillbirth
  • Neonatal sepsis
  • Preeclampsia
  • Respiratory tract infections
  • Chronic Sinusitis
  • Tonsilitis
  • Oral infections
  • Periodontitis
  • Gingivitis
  • Endodontic infections
  • Cardiovascular disorders
  • Atherosclerosis
  • Cerebral aneurysm

 

 

How to lower your risk of heart disease?

People with gum disease are more likely to experience a heart attack, stroke, or other cardiovascular issues.

Preventing gum disease through proper dental hygiene may reduce the risk of heart disease, highlighting the importance of regular dental checkups and early treatment of any gum issues for overall health improvement.

So, practicing good dental hygiene can help:

  • Brush and floss daily
  • See a dentist every six months for a cleaning (and treatment if there are signs of gum disease)
  • Quit smoking

 

In addition to these tips, the American Heart Association offers a checklist that recommends ways to improve and maintain heart health.

It’s important to note that not everyone with heart disease has gum disease. The reverse is also true— a gum infection does not automatically signify cardiovascular disease.

Conclusion

Although F. nucleatum is found mainly in the oral cavity, it is linked not only to gum disease but also to serious health issues like heart disease. This bacterium’s ability to move from the mouth to other parts of the body shows how poor oral hygiene can have far-reaching effects beyond just your teeth and gums.

Research continues to uncover these connections and underlines the importance of maintaining good oral health in order to prevent various diseases and stay healthy overall.

 

The GIDEON Difference

GIDEON is one of the most well-known and comprehensive global databases for infectious diseases. Data is refreshed daily, and the GIDEON API allows medical professionals and researchers access to a continuous stream of data. Whether your research involves quantifying data, learning about specific microbes, or testing out differential diagnosis tools– GIDEON has you covered with a program that has met standards for accessibility excellence.

Learn about more bacterial infections on the GIDEON platform.

References

[1]“Cardiovascular diseases (CVDs),” Who.int. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). [Accessed: 25-Sep-2024].
[2]S. James Booth, “Fusobacterium infections☆,” in Reference Module in Biomedical Sciences, Elsevier, 2014.
[3]Y. W. Han, “Fusobacterium nucleatum Interaction with Host Cells,” Oral Microbial Communities. Wiley, p. 221, 02-Aug-2011.
[4]S. Chaushu et al., “Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease,” PLoS Pathog., vol. 8, no. 3, p. e1002601, 2012.
[5]J. Zhou, L. Liu, P. Wu, L. Zhao, and Y. Wu, “Fusobacterium nucleatum accelerates atherosclerosis via macrophage-driven aberrant proinflammatory response and lipid metabolism,” Front. Microbiol., vol. 13, 2022.
[6]A. L. Truant, S. Menge, K. Milliorn, R. Lairscey, and M. T. Kelly, “Fusobacterium nucleatum pericarditis,” J. Clin. Microbiol., vol. 17, no. 2, pp. 349–351, 1983.
[7]M. Febbraio, C. B. Roy, and L. Levin, “Is there a causal link between periodontitis and cardiovascular disease? A concise review of recent findings,” Int. Dent. J., vol. 72, no. 1, pp. 37–51, 2022.
[8]H. Liu, Y. Liu, W. Fan, and B. Fan, “Fusobacterium nucleatum triggers proinflammatory cell death via Z-DNA binding protein 1 in apical periodontitis,” Cell Commun. Signal., vol. 20, no. 1, 2022.
[9]J. O’Brien, H. Hayder, Y. Zayed, and C. Peng, “Overview of MicroRNA biogenesis, mechanisms of actions, and circulation,” Front. Endocrinol. (Lausanne), vol. 9, 2018.
[10]S. Liu et al., “The host shapes the gut Microbiota via fecal MicroRNA,” Cell Host Microbe, vol. 19, no. 1, pp. 32–43, 2016.
[11]A. Swidsinski et al., “Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum,” Gut, vol. 60, no. 1, pp. 34–40, 2009.
[12]I. Brook, “Fusobacterial infections in children,” Curr. Infect. Dis. Rep., vol. 15, no. 3, pp. 288–294, 2013.
[13]L. Wolff, D. Martiny, V. Y. M. Deyi, E. Maillart, P. Clevenbergh, and N. Dauby, “COVID-19-associated Fusobacterium nucleatum bacteremia, Belgium,” Emerg. Infect. Dis., vol. 27, no. 3, pp. 975–977, 2020.
[14]P. J. Ford et al., “Inflammation, heat shock proteins and periodontal pathogens in atherosclerosis: an immunohistologic study,” Oral Microbiol. Immunol., vol. 21, no. 4, pp. 206–211, 2006.
[15]C. A. Brennan and W. S. Garrett, “Fusobacterium nucleatum — symbiont, opportunist and oncobacterium,” Nat. Rev. Microbiol., vol. 17, no. 3, pp. 156–166, 2019.
[16]Y. W. Han, “Fusobacterium nucleatum: a commensal-turned pathogen,” Curr. Opin. Microbiol., vol. 23, pp. 141–147, 2015.
[17]S. Hopkins et al., “Oral health and cardiovascular disease,” Am. J. Med., vol. 137, no. 4, pp. 304–307, 2024.
[18]“Life’s Essential 8TM Your checklist for lifelong good health,” Heart.org. [Online]. Available: https://www.heart.org/en/healthy-living/healthy-lifestyle/lifes-essential-8. [Accessed: 25-Sep-2024].
Author
Chandana Balasubramanian

Chandana Balasubramanian is an experienced healthcare executive who writes on the intersection of healthcare and technology. She is the President of Global Insight Advisory Network, and has a Masters degree in Biomedical Engineering from the University of Wisconsin-Madison, USA.

Articles you won’t delete.
Delivered to your inbox weekly.

This field is for validation purposes and should be left unchanged.